Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Clinical trial NCT05704985 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05704985
Sponsor: DEKA Biosciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Colorectal Cancer Pancreas Cancer Non Small Cell Lung Cancer Head and Neck Cancer Gynecologic Cancer Skin Cancer Kidney Cancer

Start date: 2023-04-03
Primary completion: 2025-07-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.